| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.80B | +4.4% |
| R&D Expense | $8.0M | +33.3% |
| SG&A Expense | $581.0M | +2.3% |
| Operating Income | $1.29B | +11.0% |
| Pre-tax Income | $1.36B | +2.0% |
| Income Tax | $369.0M | +3.7% |
| Net Income | $929.0M | +2.0% |
| EPS (Basic) | $2.52 | +7.7% |
| EPS (Diluted) | $2.51 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $506.0M | -30.0% |
| Short-term Investments | $878.0M | -21.7% |
| Accounts Receivable | $95.0M | +20.3% |
| Inventory | $438.0M | +8.1% |
| Current Assets | $2.36B | -12.5% |
| Total Assets | $10.78B | -3.0% |
| Current Liabilities | $2.25B | -1.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.47B | +3.3% |
| Capital Expenditures | $626.0M | -11.2% |
| Investing Cash Flow | -$5.0M | +97.2% |
| Financing Cash Flow | -$1.69B | -3.2% |
| Free Cash Flow | $840.0M | +17.6% |
| +7.7% |
| Total Liabilities |
| $4.68B |
| -0.2% |
| Stockholders' Equity | $5.38B | -6.1% |